Beta-cell Response to Incretin Hormones in Cystic Fibrosis

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cystic FibrosisPancreatic Insufficiency
Interventions
DRUG

GLP-1

Each subject in this arm will receive GLP-1 infusion and a placebo infusion during a GPA test.

DRUG

GIP

Each subject in this arm will receive GIP infusion and placebo during a GPA test.

Trial Locations (1)

19060

RECRUITING

Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

lead

University of Pennsylvania

OTHER